Dr. Olivia Lara, from the division of Gynecologic Oncology at The University of North Carolina at Chapel Hill School of Medicine has been named a recipient of the Robert A. Winn Diversity in Clinical Trials: Career Development Award (Winn CDA). Chosen for the fourth cohort of this esteemed program, Dr. Lara’s selection underscores her exceptional contributions to community-focused clinical research.
The award, supported by The Bristol Myers Squibb Foundation, provides a two-year grant of $120,000 annually. This recognition celebrates Dr. Lara’s impressive achievements and potential in advancing diversity within clinical trials. Her groundbreaking work promises to make significant impacts in the field, marking a significant step forward in her career.
The Winn CDA is a two-year program designed for early-stage investigator physicians and aims to support them in becoming independent clinical trial investigators. “The Winn Awards is the nation’s premiere program to develop and support the next generation of world-class community-oriented professionals to advance diversity in clinical trials,” according to the site.
Congratulations to Dr. Olivia Lara on this well-deserved honor!